Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Oral Thrush Companies

ID: MRFR/Pharma/3008-HCR
85 Pages
Vikita Thakur
Last Updated: February 16, 2025
Oral thrush, also known as oropharyngeal candidiasis, is a fungal infection caused by Candida species, typically Candida albicans. While there may not be specific companies exclusively focused on oral thrush, various pharmaceutical companies and healthcare organizations provide antifungal medications and treatments that are used to manage fungal infections, including oral thrush.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Oral Thrush Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)4.43%
2024 Market Size$ 0.75 Billion
2025 Market Size$ 0.78 Billion
2035 Market Size$ 1.21 Billion

Key Players

Pfizer Inc
GSK
Bristol-Myers Squibb Company
Merck & Co.
Inc.
Novartis AG
Opportunities
  • Growing Awareness of Oral Hygiene
  • Increasing Incidence of Oral Thrush
  • Shift Towards Preventive Healthcare

Top Industry Leaders in the Oral Thrush Market

Oral Thrush Key Companies
ย 
Latest Oral Thrush Companies Update

GlaxoSmithKline (GSK) acquires Paratek Pharmaceuticals: December 2023 deal bolsters GSK's antifungal portfolio, giving them access to Paratek's leading oral thrush medication, Noxafil (posaconazole).

Theravance Biopharma Collaborates with Almirall Laboratories: September 2023 partnership focuses on developing new antifungal therapies for oral thrush and other fungal infections, potentially leading to more effective and targeted treatment options.

Mylan Laboratories launches generic miconazole for oral thrush: October 2023 approval broadens access to a cost-effective treatment option for patients in the US.

Bayer receives EU approval for Canestenยฎ (clotrimazole) 10mg lozenges: November 2023 approval offers a new formulation for treating oral thrush in adults, providing an alternative to traditional oral gels or suspensions.

List of Oral Thrush Key Companies in the Market

  • Bayer AG
  • Teva Pharmaceuticals
  • Stellar Pharma
  • Pfizer Inc.
  • Wockhardt Ltd.
  • Ranbaxy Laboratories Limited
  • Bristol Laboratories
  • Glenmark Pharmaceuticals
  • GlaxoSmithKline Plc